Gonadotropin Suppression During Mini‐Puberty as an Early Biomarker of Classic 21‐Hydroxylase Deficiency
Endocrinology, Diabetes & Metabolism · 2026-09 · 9 (5)
DOI: 10.1002/edm2.70317 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrinology, Diabetes & Metabolism, online erschienen am 02.09.2026. Verfasst von Ryosei Iemura und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics and Developmental Biology, Institute of Science Tokyo, Tokyo, Japan. Hauptthemen laut MEDLINE: Adrenal Hyperplasia, Congenital, Luteinizing Hormone, Follicle Stimulating Hormone. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development.
Abstract (Originalsprache)
Introduction
Newborn screening (NBS) for congenital adrenal hyperplasia caused by 21‐hydroxylase deficiency (21OHD) relies on elevated 17‐hydroxyprogesterone (17OHP) levels but is limited by a high false‐positive rate and difficulty in distinguishing classic from non‐classic forms. To evaluate whether the suppression of serum luteinizing hormone (LH) and follicle‐stimulating hormone (FSH) during mini‐puberty can serve as an early biomarker of classic 21OHD.
Methods
We conducted a retrospective cohort study of 37 infants evaluated for suspected 21OHD between 2013 and 2025. Subjects were classified as classic (C), non‐classic (NC), or false‐positive (FP) based on biochemical and genetic confirmation. Neonatal serum LH and FSH levels were compared among groups, and receiver operating characteristic (ROC) analyses were performed.
Results
LH and FSH levels were significantly suppressed in classic 21OHD compared with NC and FP cases ( p < 0.001). Gonadotropin concentrations demonstrated a stepwise pattern (C
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics and Developmental Biology, Institute of Science Tokyo, Tokyo, Japan.
- Department of Pediatrics, Chiba Kaihin Municipal Hospital, Chiba, Japan.
- Department of Life Science and Bioethics, Institute of Science Tokyo, Tokyo, Japan.
- Division of Endocrinology and Metabolism, National Center for Child Health and Development, Tokyo, Japan.
ORCID-Profile: Ryosei Iemura, Haruki Yamano, Hisae Nakatani, Shizuka Kirino, Yoko Saito, Eriko Adachi, Atsumi Tsuji-Hosokawa, Kenichi Kashimada, Kei Takasawa
Förderung
- Japan Agency for Medical Research and Development
Zitieren
APA
Iemura, R., Suzuki, Y., Gau, M., Orimoto, R., Yamano, H., Nakatani, H., Kirino, S., Saito, Y., Adachi, E., Tsuji-Hosokawa, A., Kashimada, K., & Takasawa, K. (2026). Gonadotropin Suppression During Mini‐Puberty as an Early Biomarker of Classic 21‐Hydroxylase Deficiency. Endocrinology, Diabetes & Metabolism, 9(5). https://doi.org/10.1002/edm2.70317
Vancouver
Iemura R, Suzuki Y, Gau M, Orimoto R, Yamano H, Nakatani H, et al. Gonadotropin Suppression During Mini‐Puberty as an Early Biomarker of Classic 21‐Hydroxylase Deficiency. Endocrinology, Diabetes & Metabolism. 2026;9(5). doi:10.1002/edm2.70317
BibTeX
@article{Iemura2026,
author = {Iemura, Ryosei and Suzuki, Yuri and Gau, Maki and Orimoto, Ryuta and Yamano, Haruki and Nakatani, Hisae and Kirino, Shizuka and Saito, Yoko and Adachi, Eriko and Tsuji-Hosokawa, Atsumi and Kashimada, Kenichi and Takasawa, Kei},
title = {Gonadotropin Suppression During Mini‐Puberty as an Early Biomarker of Classic 21‐Hydroxylase Deficiency},
journal = {Endocrinology, Diabetes & Metabolism},
year = {2026},
volume = {9},
number = {5},
doi = {10.1002/edm2.70317}
}
EUVIMED